HERON THERAPEUTICS INC's ticker is and the CUSIP is 427746902. A total of 3 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969,436 | +139186.8% | 941,200 | +156766.7% | 0.00% | – |
| Q2 2023 | $696 | -42.4% | 600 | -25.0% | 0.00% | – |
| Q1 2023 | $1,208 | -79.0% | 800 | -65.2% | 0.00% | – |
| Q4 2022 | $5,750 | -55.8% | 2,300 | -23.3% | 0.00% | – |
| Q3 2022 | $13,000 | -60.6% | 3,000 | -74.4% | 0.00% | – |
| Q2 2022 | $33,000 | -89.0% | 11,700 | -77.6% | 0.00% | – |
| Q1 2022 | $299,000 | +86.9% | 52,300 | +198.9% | 0.00% | – |
| Q4 2021 | $160,000 | -79.8% | 17,500 | -76.4% | 0.00% | -100.0% |
| Q3 2021 | $791,000 | -43.8% | 74,000 | -18.4% | 0.00% | -50.0% |
| Q2 2021 | $1,408,000 | +3.4% | 90,700 | +8.0% | 0.00% | 0.0% |
| Q1 2021 | $1,362,000 | +138.5% | 84,000 | +211.1% | 0.00% | +100.0% |
| Q4 2020 | $571,000 | +41.0% | 27,000 | -1.1% | 0.00% | 0.0% |
| Q3 2020 | $405,000 | -70.4% | 27,300 | -70.7% | 0.00% | -83.3% |
| Q2 2020 | $1,370,000 | -2.2% | 93,100 | -22.0% | 0.01% | -45.5% |
| Q1 2020 | $1,401,000 | +104.8% | 119,300 | +310.0% | 0.01% | +120.0% |
| Q4 2019 | $684,000 | +43.4% | 29,100 | +12.8% | 0.01% | +25.0% |
| Q3 2019 | $477,000 | +1.1% | 25,800 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $472,000 | -5.8% | 25,400 | +23.9% | 0.00% | -33.3% |
| Q1 2019 | $501,000 | -51.8% | 20,500 | -48.9% | 0.01% | -33.3% |
| Q4 2018 | $1,040,000 | -62.4% | 40,100 | -54.1% | 0.01% | -59.1% |
| Q3 2018 | $2,763,000 | +129.5% | 87,300 | +181.6% | 0.02% | +120.0% |
| Q2 2018 | $1,204,000 | -45.9% | 31,000 | -61.5% | 0.01% | -54.5% |
| Q1 2018 | $2,225,000 | +220.1% | 80,600 | +109.9% | 0.02% | +340.0% |
| Q4 2017 | $695,000 | -38.0% | 38,400 | -44.7% | 0.01% | -50.0% |
| Q3 2017 | $1,121,000 | +2569.0% | 69,400 | +2213.3% | 0.01% | – |
| Q2 2017 | $42,000 | -51.2% | 3,000 | -47.4% | 0.00% | -100.0% |
| Q1 2017 | $86,000 | -86.5% | 5,700 | -88.3% | 0.00% | -83.3% |
| Q4 2016 | $639,000 | -3.5% | 48,800 | +27.1% | 0.01% | -14.3% |
| Q3 2016 | $662,000 | -2.9% | 38,400 | +1.6% | 0.01% | -12.5% |
| Q2 2016 | $682,000 | -27.4% | 37,800 | -23.6% | 0.01% | -38.5% |
| Q1 2016 | $940,000 | +89.1% | 49,500 | +166.1% | 0.01% | +116.7% |
| Q4 2015 | $497,000 | -94.9% | 18,600 | -95.4% | 0.01% | -95.6% |
| Q3 2015 | $9,841,000 | +69.4% | 403,300 | +116.4% | 0.14% | +67.9% |
| Q2 2015 | $5,808,000 | +546.8% | 186,400 | +202.1% | 0.08% | +478.6% |
| Q1 2015 | $898,000 | +11125.0% | 61,700 | +6070.0% | 0.01% | – |
| Q3 2014 | $8,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 100,000 | $279,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 11,700 | $33,000 | 0.00% |
| SIMPLEX TRADING, LLC | 8,400 | $23,000 | 0.00% |